Chapter 77: Hodgkin lymphoma: Clinical manifestations, stageing, and therapyDiehl, VolkerKlimm, BeateRe, Daniel
Major acute manifestations: Vasoocclusive events: present suddenly with severe pain and infarction of the affected tissueInfection (see complications below for more details):[11] Sepsis Pneumonia Meningitis Anemia Transient aplastic episode: worsening of anemic symptoms plus purpura, petechiae , ...
Heart failure (HF) refers to a complex condition resulting from the structural and/or functional inability of the heart to supply a normal cardiac output to meet metabolic needs. In HF, impaired ventricular filling or ejection of blood leads to fatigue , dyspnea , and fluid retention or edema...
Classical Hodgkin Lymphoma KEYTRUDA is indicated for the treatment of adult patients with relapsed or refractory classical Hodgkin lymphoma (cHL). KEYTRUDA is indicated for the treatment of pediatric patients with r...
An oral presentation will report on data from the open-label, dose-escalation study of C-CAR039, an autologous anti-CD20/CD19 bispecific CAR-T cell therapy, in patients with relapsed or refractory B-cell non-Hodgkin’s lymp...
terms of anti-glycoprotein E humoral immune response to the adjuvanted recombinant zoster vaccine at month 2 in all participants, excluding those with non-Hodgkin B-cell lymphoma and chronic lymphocytic leukemia (CLL); and evaluation of the anti-glycoprotein E humoral immune responses to the vaccine...
Non-Hodgkin’s Lymphoma (NHL) A large meta-analysis of 15 case–control studies and three prospective studies with a total number of 12,235 CHC patients estimated the pooled RR of NHL among HCV-positive individuals as 2.5 (95% CI 2.1–3.0) [39]. Another meta-analysis conducted primarily ...
Analysis of Clinical Manifestations and Prognosis of 92 Cases with Non-Hodgkin's Lymphoma 非霍奇金淋巴瘤临床研究预后幸存率OBJECTIVE To analyze the risk factors and influence of various treatments on the prognosis of non-Hodgkin's lymphoma (NHL). METHODS Clinical data of 92 patients with NHL from...
Pulmonary embolism (PE) is a potentially fatal condition that occurs as a result of intraluminal obstruction of the main pulmonary artery or its branches.
Kawasaki disease is a medium-sized necrotizing febrile vasculitis that predominantly affects children < 5 years of age.